GB2439675A - Chemical interaction with metabolites in organism - Google Patents
Chemical interaction with metabolites in organismInfo
- Publication number
- GB2439675A GB2439675A GB0719562A GB0719562A GB2439675A GB 2439675 A GB2439675 A GB 2439675A GB 0719562 A GB0719562 A GB 0719562A GB 0719562 A GB0719562 A GB 0719562A GB 2439675 A GB2439675 A GB 2439675A
- Authority
- GB
- United Kingdom
- Prior art keywords
- drug
- clinical
- organism
- toxicity
- throughput data
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B35/00—ICT specially adapted for in silico combinatorial libraries of nucleic acids, proteins or peptides
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
- G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
- G16C20/30—Prediction of properties of chemical compounds, compositions or mixtures
-
- C40B30/02—
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B5/00—ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
- G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
- G16C20/60—In silico combinatorial chemistry
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B45/00—ICT specially adapted for bioinformatics-related data visualisation, e.g. displaying of maps or networks
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
- G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
- G16C20/80—Data visualisation
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Theoretical Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Evolutionary Biology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physiology (AREA)
- Computing Systems (AREA)
- Crystallography & Structural Chemistry (AREA)
- Library & Information Science (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
A system is provided for the prediction of human drug metabolism and toxicity of novel compounds. The system enables the visualization of pre-clinical and clinical high- throughput data in the context of a complete biological organism. Substructure and similarity structure searches can be performed using the underlying databases of xenobiotics, active ligands, and endobiotics. The system also has an analytical component for the parsing, integration, and network analysis of genomics, proteomics, and metabolomics high-throughput data. From this information, the system further generates networks around proteins, genes and compounds to assess toxicity and drug-drug interactions.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US66269905P | 2005-03-17 | 2005-03-17 | |
PCT/US2006/010053 WO2006099624A2 (en) | 2005-03-17 | 2006-03-17 | Chemical interaction with metabolites in organism |
Publications (2)
Publication Number | Publication Date |
---|---|
GB0719562D0 GB0719562D0 (en) | 2007-11-14 |
GB2439675A true GB2439675A (en) | 2008-01-02 |
Family
ID=36992486
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0719562A Withdrawn GB2439675A (en) | 2005-03-17 | 2006-03-17 | Chemical interaction with metabolites in organism |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1866824A4 (en) |
GB (1) | GB2439675A (en) |
WO (1) | WO2006099624A2 (en) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6365131B1 (en) * | 1997-10-31 | 2002-04-02 | J. B. Chemicals & Pharmaceuticals Ltd. | Pharmaceutical dental formulation for topical application of metronidazole benzoate, chlorhexidine gluconate and local anesthetic |
-
2006
- 2006-03-17 EP EP06748475A patent/EP1866824A4/en not_active Withdrawn
- 2006-03-17 WO PCT/US2006/010053 patent/WO2006099624A2/en active Application Filing
- 2006-03-17 GB GB0719562A patent/GB2439675A/en not_active Withdrawn
Non-Patent Citations (1)
Title |
---|
Not yet advised * |
Also Published As
Publication number | Publication date |
---|---|
WO2006099624A9 (en) | 2006-11-09 |
WO2006099624A3 (en) | 2007-12-06 |
EP1866824A4 (en) | 2009-08-05 |
WO2006099624A2 (en) | 2006-09-21 |
GB0719562D0 (en) | 2007-11-14 |
EP1866824A2 (en) | 2007-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kustatscher et al. | Understudied proteins: opportunities and challenges for functional proteomics | |
Prasad et al. | Toward a consensus on applying quantitative liquid chromatography‐tandem mass spectrometry proteomics in translational pharmacology research: a white paper | |
Samaras et al. | ProteomicsDB: a multi-omics and multi-organism resource for life science research | |
Fontanesi | Metabolomics and livestock genomics: Insights into a phenotyping frontier and its applications in animal breeding | |
Hoffmann et al. | mzTab-M: a data standard for sharing quantitative results in mass spectrometry metabolomics | |
Kenyon et al. | Defining the mandate of proteomics in the post-genomics era: workshop report | |
Mustacchi et al. | Yeast systems biology to unravel the network of life | |
Wiśniewski et al. | Multiple-enzyme-digestion strategy improves accuracy and sensitivity of label-and standard-free absolute quantification to a level that is achievable by analysis with stable isotope-labeled standard spiking | |
Vinaiphat et al. | Prospects for proteomics in kidney stone disease | |
Musa et al. | Comprehensive proteomic investigation of ebf1 heterozygosity in Pro-B lymphocytes utilizing data independent acquisition | |
Neto et al. | Expanding urinary metabolite annotation through integrated mass spectral similarity networking | |
Ivanov et al. | Interlaboratory studies and initiatives developing standards for proteomics | |
Yu et al. | Tandem mass spectrometry molecular networking as a powerful and efficient tool for drug metabolism studies | |
Van Rijswijk et al. | The future of metabolomics in ELIXIR | |
Hoffman et al. | Comparison of quantitative mass spectrometry platforms for monitoring kinase ATP probe uptake in lung cancer | |
Davies et al. | ADME SARfari: comparative genomics of drug metabolizing systems | |
Klann et al. | Instrument logic increases identifications during mutliplexed translatome measurements | |
Sui et al. | Robust Capillary-and Micro-Flow Liquid Chromatography–Tandem Mass Spectrometry Methods for High-Throughput Proteome Profiling | |
Peng et al. | Comparison of database searching programs for the analysis of single-cell proteomics data | |
Zhang et al. | Strain-specific peptide (SSP) interference reference sample: a genetically encoded quality control for isobaric tagging strategies | |
Weckwerth et al. | The multinational Arabidopsis steering subcommittee for proteomics assembles the largest proteome database resource for plant systems biology | |
Nice | Challenges for omics technologies in the implementation of personalized medicine | |
Starkey et al. | Proteomics and systems biology for understanding diabetic nephropathy | |
Prasad et al. | Towards a consensus on applying quantitative LC-MS/MS Proteomics in translational pharmacology research: a White Paper | |
Deng et al. | freeQuant: A mass spectrometry label‐free quantification software tool for complex proteome analysis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WAP | Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1) |